HIGH BLOOD PRESSURE associated with sympathetic overactivity is often associated with cardiovascular related mortality and/or morbidity. A therapeutic approach now considered for the treatment of resistant forms of the disease involves the selective denervation of the kidney (16, 51, 52, 57) . Kidney function is known to be of primary importance in the long-term regulation and maintenance of arterial pressure (24). However, it is well documented that the autonomic nervous system also plays a critical role in the control of arterial pressure and in the pathogenesis of hypertension (1, 2, 36, 41), especially as it is able to modify renal function (19, 29) . The autonomic nervous system and kidney are linked through renal nerves that are composed of both efferent sympathetic and afferent sensory fibers (19, 29) . Although considerable evidence exists suggesting an overexcitation of the sympathetic nervous system in conjunction with neurohormonal factors in the pathogenesis of resistant forms of hypertension, these data do not unequivocally demonstrate whether the effects on arterial pressure following renal denervation are mediated by efferent renal sympathetic nerves or afferent sensory nerves originating in the kidney. This is especially true as afferent signals from the kidney alter the activity of preautonomic neurons in central sites involved in controlling arterial pressure and sympathetic nervous system activity (15), as clearly demonstrated in the article by Xu et al. (50), published in this issue of the American Journal of Physiology-Heart and Circulatory Physiology.
. Furthermore, these renal chemoreceptors have been shown to be activated following intrarenal infusions of substance-P, bradykinin, and adenosine (27, 29 -34) . In addition, capsaicin, through activation of the nonselective cation channel transient receptor potential vanilloid 1 (32, 49) , has been shown to activate renal chemoreceptors. Prostaglandin production has also been reported to activate these renal chemoreceptors, and inhibition of prostaglandin synthesis prevents the selective activation of R2 chemoreceptors (30) . Finally, there are data suggesting that renal chemoreceptors also respond to cyclosporine A through a calcineurin-dependent process (56) . Calcineurin inhibitors have been shown to enhance sympathetic neurotransmission by stimulating renal sensory nerve endings that contain synapsin-positive microvesicles (55) . Renal mechanoreceptors monitor hydrostatic pressure changes in the kidney (35, 47) and at least two types of renal mechanoreceptors appear to exist: those with no spontaneous activity and those with tonic activity. However, both types of mechanoreceptors respond to increases in renal artery, venous, and/or pelvic pressure (35, 47) .
These renal receptors through their central connections are able to influence cardiovascular function not only by altering the release of vasopressin from the neurohypophysis (6, 11, 17, 18, 44) but also by increasing sympathetic nerve discharge to different vascular beds (7, 48) and the adrenal medulla (36) and through renorenal reflexes to alter kidney function (37, 38) . Thus it is now accepted that afferent renal nerves and the central structures that integrate afferent renal nerve information may play an important role in the development and maintenance of hypertension (14, 15, 20, 22, 25, 28) . Ciriello and colleagues were the first to identify central sites of integration of afferent renal nerve information (4, 7, 8, 10 -14, 17, 18, 43, 45, 46) . Specifically related to the recent article by Xu et al. (50) are the earlier findings that activation of afferent renal nerves in both the rat (11, 17, 18, 43, 45, 46) and cat (7, 8) evoked neuronal responses in the hypothalamic paraventricular nucleus (PVN). In earlier studies the output of vasopressin and oxytocin neurons to the posterior pituitary was primarily investigated (7, 11, 17, 18) , as it had been reported that activation of afferent renal nerves resulted in the release of vasopressin into the circulation (6, 44) . A study was also completed showing that direct PVN-spinal pathways that terminated within the intermediolateral cell column received afferent renal nerve inputs, suggesting a possible pathway by which afferent renal nerves could activate preganglionic neurons and arterial pressure (8) . The study by Xu et al. (50) extends this line of investigation into central structures and pathways involved in integrating afferent renal nerve information and in the control of arterial pressure by examining the responses of PVN neurons that project directly to sympathoexcitatory sites within the rostral ventrolateral medulla (RVLM) to activation of afferent renal nerves. The RVLM is well known for its critical role in the function of the reflex regulation and maintenance of vasomotor tone (23) . This well-designed and performed study by the authors has shown that spontaneously active neurons within the PVN antidromically activated by stimulation of RVLM pressor sites increased their discharge rate through the activation of N-methyl-D-aspartate receptors during afferent renal nerve stimulation. The authors interpreted their data to suggest that renal mechanoreceptor and/or chemoreceptor afferent information is relayed to PVN preautonomic neurons for integration before activating sympathetic premotor neurons in the RVLM. Additionally, these PVN preautonomic neurons were found to be inhibited during the reflex activation of arterial baroreceptors. This observation further supports the conclusion that the PVN preautonomic neurons likely functioned as components of descending sympathoexcitatory pathways. Furthermore, the authors demonstrated that these PVN neurons responding to afferent renal nerves were also activated by cardiac receptors. The PVN has been shown to be an integral part of central pathways relaying cardiac receptor afferent information and activating sympathoexcitatory reflexes (42, 53, 54) . Thus it is not unreasonable to suggest that afferent renal nerve inputs to PVN preautonomic sympathoexcitatory neurons projecting to RVLM may in fact exacerbate sympathetic cardiac reflexes elicited during chronic heart failure (9, 21, 53) . The interaction of these functionally similar inputs within PVN with regard to driving sympathetic output may also contribute to a sustained hypertension.
In the study, the authors chose specifically to systematically study spontaneously active neurons within the PVN before determining whether they were RVLM projecting neurons. A population of tonically active neurons was also found within PVN that responded to afferent renal nerve activation but were not antidromically activated, suggesting that these were neurons likely projecting to other central sites, including the posterior pituitary (11) . However, the authors could have also entertained the possibility that not all neurons projecting to the RVLM were spontaneously active and that these neurons may have formed a larger population of PVN-RVLM projecting neurons. Several earlier studies investigating renal afferent inputs to the hypothalamus showed a number of silent neurons were activated by stimulation of afferent renal nerves (4, 12). Interestingly, not all renal receptors are tonically active (35, 39, 40, 47) , suggesting the possibility that a relationship may exist between the activity of PVN neurons and the activity of renal receptors. The authors may wish to do future studies to explore the possibility that the afferent renal input contributed to the tonic activity of PVN neurons and that this input was renal receptor specific. Also of interest is the finding that all PVN-RVLM neurons studied were excited by afferent renal nerve inputs, which could be interpreted to suggest that information from renal chemoreceptors, rather than mechanoreceptors, was the primary input to these neurons. Additionally, examining the interaction between the inputs of a specific renal receptor type and with a specific cardiac receptor type on the output of the PVN-RVLM neurons would be of considerable interest as both renal and cardiac afferents relay through PVN, and their combined effects may be to exacerbate the sympathetic drive during conditions of renal or cardiac stress as observed in heart failure conditions or hypertension.
A number of studies have examined the role of renal nerves on arterial pressure and on the maintenance of hypertension in experimental models (15) and more recently in humans (3, 15, 16, 26, 51, 52, 57) . In recent clinical studies, either surgical sympathectomy involving renal nerves or endovascular radiofrequency ablation of renal nerves has been shown to cause significant long-lasting reductions in arterial pressure and heart rate (16, 51, 52, 57) . Thus it is likely that renal nerve transection could become a commonly used procedure to treat resistant forms of hypertension and other chronic diseases associated with enhanced sympathetic activation (3, 51, 52, 57) . However, data supporting the long-term safety and efficacy of renal denervation are limited, and thus a considerable effort should be placed in following patients who have had this procedure. Additionally, an emphasis should be placed on research to identify the patient population that would benefit most from this procedure. Furthermore, one of the primary unanswered questions that remain is whether the effects on sympathetic nerve activity and arterial pressure are due to the removal of efferent renal sympathetic fibers or to afferent renal fibers. Although the reduction in arterial pressure following renal denervation could be accounted for by the elimination of efferent sympathetic nerves to the kidney, it may be in fact that both afferent and efferent renal nerves are contributing to the overall effect. This possibility is supported by the observation that an increase in sympathetic activity alters afferent renal nerve activity by the release of norepinephrine, which acts at ␣ 1 -and ␣ 2 -adrenergic receptors on afferent renal fibers (30) . These findings suggest that efferent sympathetic nerves can alter the sensitivity of renal chemoreceptors and that activation of these afferent renal receptors elicits increases in sympathetic activity (29) . Thus the reflex changes in efferent sympathetic activity evoke similar changes in afferent renal nerve activity (30) , which in turn activates efferent sympathetic activity. Thus, in a pathophysiological condition where there is an initial increase in sympathetic activity to the kidney, the elevated sympathetic activity activates a positive feedback system through afferent renal nerves that may be the sustaining factor in resistant forms of hypertension. This reciprocal relationship between kidney receptors and central structures that drive sympathetic activity such as the PVN and RVLM shown in the study by Xu et al. (50) may play a critical role in cardiovascular disease associated with increased sympathetic activity such as hypertension, although the mechanisms still remain to be elucidated. Therefore, a greater understanding of the neuronal circuitry and the neurotransmitters involved mediating afferent renal information, and its putative interaction with other cardiovascular reflexes may be of considerable significance in developing therapeutic strategies for alleviating the long-term cardiovascular consequences associated with hypertension and other cardiovascular disease such as heart failure.
